Implications for Eczema Vaccinatum Selective Killing of Vaccinia Virus by LL-37 :

[1]  F. Charatan.  US investigates 82 cases of monkeypox virus , 2003, BMJ.

[2]  Takaaki Ohtake,et al.  Biology and clinical relevance of naturally occurring antimicrobial peptides. , 2002, The Journal of allergy and clinical immunology.

[3]  Tomas Ganz,et al.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.

[4]  R. Gallo,et al.  The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. , 2002, Journal of the American Academy of Dermatology.

[5]  D. Leung,et al.  Smallpox vaccination: Risk considerations for patients with atopic dermatitis. , 2002, The Journal of allergy and clinical immunology.

[6]  David C Tscharke,et al.  Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. , 2002, The Journal of general virology.

[7]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[8]  G. Griffiths,et al.  Structure and Assembly of Intracellular Mature Vaccinia Virus: Thin-Section Analyses , 2001, Journal of Virology.

[9]  V. Nizet,et al.  Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. , 2001, The Journal of investigative dermatology.

[10]  R. Welsh,et al.  Innate Immunity to Viruses: Control of Vaccinia Virus Infection by γδ T Cells1 , 2001, The Journal of Immunology.

[11]  Geoffrey L. Smith,et al.  Intracellular and extracellular vaccinia virions enter cells by different mechanisms. , 1998, The Journal of general virology.

[12]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[13]  H. Wigzell,et al.  The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders* , 1997, The Journal of Biological Chemistry.

[14]  T. Ganz,et al.  Purification and characterization of defensins from cystic fibrosis sputum , 1997, Inflammation Research.

[15]  A. Buchan,et al.  Growth of herpes simplex type 1 on skin explants of atopic eczema , 1996, Clinical and experimental dermatology.

[16]  M. Ericsson,et al.  Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network , 1994, Journal of virology.

[17]  B. Moss,et al.  Identification, sequence, and expression of the gene encoding a Mr 35,000 subunit of the vaccinia virus DNA-dependent RNA polymerase. , 1991, The Journal of biological chemistry.

[18]  R. Gennaro,et al.  Inactivation of herpes simplex virus by protein components of bovine neutrophil granules. , 1987, Antiviral research.

[19]  R I Lehrer,et al.  Direct inactivation of viruses by human granulocyte defensins , 1986, Journal of virology.

[20]  T. Ganz,et al.  Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity , 1985, Infection and immunity.

[21]  E. Christophers,et al.  Contrasting disease patterns in psoriasis and atopic dermatitis , 2004, Archives of Dermatological Research.

[22]  A. Waring,et al.  Evaluation of the Inactivation of Infectious Herpes Simplex Virus by Host-Defense Peptides , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[23]  H. McFarland,et al.  The Immune Response to Viruses , 1989 .

[24]  F. Fenner.  Smallpox and its eradication , 1988 .